SMS PHARMACEUTICALS LTD. (SMSPHARMA) financials

SMS PHARMACEUTICALS LTD. (SMSPHARMA) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates.[1]

Market Cap: ₹3,973Cr.
Current Price: ₹424
Stock P/E: 43.9
ROE: 11.9%
ROCE: 12.9%
Book Value: ₹85.9
Dividend Yield: 0.09%
52W High / Low: ₹494/270

In Jun 2026, SMS PHARMACEUTICALS LTD. (SMSPHARMA) reported sales ₹207 Cr and net profit ₹21 Cr.

Annual TTM: sales ₹898 Cr, net profit ₹91 Cr.

Shareholding: Promoters 68.07% (Sep 2026), FIIs 1.18% (Sep 2026), DIIs 0.19% (Sep 2026), Public 30.55% (Sep 2026), No. of Shareholders 34,904% (Sep 2026).

SMSPHARMA quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	197	173	248	196	242	210	238	207
Expenses	165	140	207	157	194	167	198	165
Operating Profit	32	33	41	39	48	44	40	42
OPM %	16%	19%	17%	20%	20%	21%	17%	20%
Other Income	1	2	1	1	1	4	3	2
Interest	5	4	5	6	6	6	5	6
Depreciation	9	9	9	10	10	10	10	10
Profit before tax	20	23	29	24	34	31	27	28
Tax %	28%	24%	29%	24%	26%	25%	23%	25%
Net Profit	14	17	21	18	25	23	21	21
EPS in Rs	1.68	2.03	2.33	2.05	2.68	2.49	2.23	2.26
Raw PDF	—	—	—	—	—	—	—	—

SMSPHARMA profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	412	563	520	522	709	783	887	898
Expenses	332	442	405	467	592	643	716	724
Operating Profit	80	121	115	55	117	140	171	174
OPM %	19%	22%	22%	10%	16%	18%	19%	19%
Other Income	5	3	5	5	4	6	8	9
Interest	12	11	19	22	24	19	23	23
Depreciation	22	22	32	32	32	34	40	40
Profit before tax	51	91	69	6	66	93	116	121
Tax %	36%	33%	1%	26%	25%	27%	25%	—
Net Profit	33	61	68	4	49	68	88	91
EPS in Rs	3.86	7.20	8.03	0.48	5.83	7.71	9.35	9.66
Dividend Payout %	6%	4%	4%	62%	7%	5%	4%	—

SMSPHARMA balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	8	8	8	8	8	9	9
Reserves	331	359	420	485	487	562	664	795
Borrowings	144	157	255	263	254	281	311	365
Other Liabilities	93	103	147	126	165	217	202	211
Total Liabilities	577	627	830	883	914	1,068	1,186	1,381
Fixed Assets	281	280	457	438	412	437	533	534
CWIP	18	42	7	11	33	30	35	116
Investments	45	45	45	45	45	45	45	52
Other Assets	232	259	321	389	424	556	573	679
Total Assets	577	627	830	883	914	1,068	1,186	1,381

SMSPHARMA cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	50	40	90	45	22	50	82	61
Cash from Investing Activity	-35	-43	-152	-27	-30	-52	-123	-132
Cash from Financing Activity	-13	-2	92	-12	-32	31	47	76
Net Cash Flow	2	-5	31	6	-39	29	5	4
Free Cash Flow	15	-3	-61	18	-7	-2	-42	-64
CFO/OP	70%	65%	88%	52%	49%	56%	73%	50%

SMSPHARMA shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	64.67%	66.27%	66.27%	68.07%	68.07%	68.07%	68.07%	68.07%
FIIs	0.31%	0.08%	0.03%	0.28%	0.04%	0.31%	0.65%	1.18%
DIIs	2.55%	2.43%	3.03%	2.88%	3.21%	3.02%	2.83%	0.19%
Public	32.47%	31.23%	30.68%	28.77%	28.69%	28.60%	28.45%	30.55%
No. of Shareholders	34,973	35,332	33,652	34,157	34,378	32,397	31,489	34,904

SMSPHARMA key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	20	43	68	34	104	122	95	89
Inventory Days	170	191	148	333	243	201	238	259
Days Payable	59	66	70	97	117	130	95	89
Cash Conversion Cycle	131	169	146	270	230	192	238	259
Working Capital Days	39	57	48	94	104	85	88	98
ROCE %	16%	13%	17%	12%	4%	11%	12%	13%

SMSPHARMAUpdated 14 Oct 2026, 23:22

Sms Pharmaceuticals Ltd.

SMSPHARMAUpdated 14 Oct 2026, 23:22

Market Cap

₹3,973Cr.

Current Price

₹424

High / Low

₹494/270

Stock P/E

43.9

ROE11.9%

ROCE12.9%

Book Value₹85.9

Face Value₹1.00

Dividend Yield0.09%

About

SMS Pharmaceuticals Ltd is a diversified and integrated pharmaceutical company with interests in Active Pharmaceutical Ingredients (API) and Intermediates.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	135	6	109	1	8	13	29	9	1.1
Sep 2023	167	6	139	1	8	15	21	12	1.42
Dec 2023	161	6	133	1	8	16	26	12	1.44
Mar 2024	246	6	212	2	8	22	26	16	1.88
Jun 2024	164	5	131	1	8	22	25	16	1.93
Sep 2024	197	5	165	1	9	20	28	14	1.68
Dec 2024	173	4	140	2	9	23	24	17	2.03
Mar 2025	248	5	207	1	9	29	29	21	2.33
Jun 2025	196	6	157	1	10	24	24	18	2.05
Sep 2025	242	6	194	1	10	34	26	25	2.68
Dec 2025	210	6	167	4	10	31	25	23	2.49
Mar 2026	238	5	198	3	10	27	23	21	2.23
Jun 2026	207	6	165	2	10	28	25	21	2.26

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	587	18	500	16	17	67	48	35	4.15
Mar 2016	611	17	522	4	19	56	26	42	4.92
Mar 2017	438	16	363	1	19	42	14	36	4.2
Mar 2018	463	15	369	2	20	60	33	40	4.78
Mar 2019	465	12	375	3	19	62	34	41	4.89
Mar 2020	412	12	332	5	22	51	36	33	3.86
Mar 2021	563	11	442	3	22	91	33	61	7.2
Mar 2022	520	19	405	5	32	69	1	68	8.03
Mar 2023	522	22	467	5	32	6	26	4	0.48
Mar 2024	709	24	592	4	32	66	25	49	5.83
Mar 2025	783	19	643	6	34	93	27	68	7.71
Mar 2026	887	23	716	8	40	116	25	88	9.35
TTM	898	23	724	9	40	121	—	91	9.66

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	68.07%
FIIs	1.18%
DIIs	0.19%
Public	30.55%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Public
Dec 2023	64.32%	0.59%	0%	35.1%
Mar 2024	64.67%	0.17%	1.98%	33.18%
Jun 2024	64.67%	0.18%	2.13%	33.03%
Sep 2024	64.67%	0.52%	2.55%	32.27%
Dec 2024	64.67%	0.31%	2.55%	32.47%
Mar 2025	66.27%	0.08%	2.43%	31.23%
Jun 2025	66.27%	0.03%	3.03%	30.68%
Sep 2025	68.07%	0.28%	2.88%	28.77%
Dec 2025	68.07%	0.04%	3.21%	28.69%
Mar 2026	68.07%	0.31%	3.02%	28.6%
Jun 2026	68.07%	0.65%	2.83%	28.45%
Sep 2026	68.07%	1.18%	0.19%	30.55%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	8	246	167	119	540	277	29	13	221	540
Mar 2016	8	286	204	158	656	370	13	21	252	656
Mar 2017	8	254	149	89	501	290	8	37	166	501
Mar 2018	8	293	146	72	519	279	8	45	187	519
Mar 2019	8	331	144	93	577	281	18	45	232	577
Mar 2020	8	359	157	103	627	280	42	45	259	627
Mar 2021	8	420	255	147	830	457	7	45	321	830
Mar 2022	8	485	263	126	883	438	11	45	389	883
Mar 2023	8	487	254	165	914	412	33	45	424	914
Mar 2024	8	562	281	217	1068	437	30	45	556	1068
Mar 2025	9	664	311	202	1186	533	35	45	573	1186
Mar 2026	9	795	365	211	1381	534	116	52	679	1381

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	59	-55	-10	-6
Mar 2016	61	-79	27	9
Mar 2017	73	-39	-33	1
Mar 2018	32	-17	-15	0
Mar 2019	50	-35	-13	2
Mar 2020	40	-43	-2	-5
Mar 2021	90	-152	92	31
Mar 2022	45	-27	-12	6
Mar 2023	22	-30	-32	-39
Mar 2024	50	-52	31	29
Mar 2025	82	-123	47	5
Mar 2026	61	-132	76	4

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	37	36	18	19	20	43	68	34	104	122	95	89
Inventory Days	81	106	114	135	170	191	148	333	243	201	238	259
Days Payable	58	79	82	49	59	66	70	97	117	130	95	89
Cash Conversion Cycle	61	63	50	105	131	169	146	270	230	192	238	259
Working Capital Days	19	19	-2	27	39	57	48	94	104	85	88	98
ROCE %	21%	16%	13%	18%	16%	13%	17%	12%	4%	11%	12%	13%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of SMS PHARMACEUTICALS LTD. (SMSPHARMA)?

The reported market capitalisation for SMS PHARMACEUTICALS LTD. (SMSPHARMA) is ₹3,973Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of SMSPHARMA?

The current price shown for SMS PHARMACEUTICALS LTD. (SMSPHARMA) on Fincrux is ₹424 with a 52-week high/low of ₹494/270.

What is the P/E ratio of SMS PHARMACEUTICALS LTD. (SMSPHARMA)?

The stock P/E for SMS PHARMACEUTICALS LTD. (SMSPHARMA) is 43.9 on Fincrux, with ROE at 11.9% and ROCE at 12.9%.

What were SMSPHARMA latest quarterly results?

For Jun 2026, SMS PHARMACEUTICALS LTD. (SMSPHARMA) reported sales ₹207 Cr and net profit ₹21 Cr (figures in ₹ crore unless noted).

What are SMSPHARMA annual sales and net profit?

For TTM, SMS PHARMACEUTICALS LTD. (SMSPHARMA) shows sales of ₹898 Cr and net profit of ₹91 Cr on the Fincrux profit & loss statement.

Who owns SMS PHARMACEUTICALS LTD. (SMSPHARMA)?

Latest shareholding for SMS PHARMACEUTICALS LTD. (SMSPHARMA) on Fincrux: Promoters 68.07% (Sep 2026), FIIs 1.18% (Sep 2026), DIIs 0.19% (Sep 2026), Public 30.55% (Sep 2026), No. of Shareholders 34,904% (Sep 2026).

Where can I find SMS PHARMACEUTICALS LTD. (SMSPHARMA) financials?

SMS PHARMACEUTICALS LTD. (SMSPHARMA) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show SMSPHARMA balance sheet and cash flow?

Yes. The SMS PHARMACEUTICALS LTD. (SMSPHARMA) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 14 October 2026 at 23:22